The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study.

Hdl Handle:
http://hdl.handle.net/10147/231540
Title:
The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study.
Authors:
Gormley, J A; Hegarty, S M; O'Grady, A; Stevenson, M R; Burden, R E; Barrett, H L; Scott, C J; Johnston, J A; Wilson, R H; Kay, E W; Johnston, P G; Olwill, S A
Affiliation:
Fusion Antibodies Ltd, Springbank Industrial Estate, Pembroke Loop Rd, Belfast BT17 0QL, Northern Ireland. julie.gormley@fusionantibodies.com
Citation:
The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study. 2011, 105 (10):1487-94 Br. J. Cancer
Journal:
British journal of cancer
Issue Date:
8-Nov-2011
URI:
http://hdl.handle.net/10147/231540
DOI:
10.1038/bjc.2011.408
PubMed ID:
21989182
Abstract:
The aim of this pilot retrospective study was to investigate the immunohistochemical expression of Cathepsin S (CatS) in three cohorts of colorectal cancer (CRC) patients (n=560).
Item Type:
Article
Language:
en
MeSH:
Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cathepsins; Chemotherapy, Adjuvant; Cohort Studies; Colorectal Neoplasms; Female; Fluorouracil; Humans; Immunohistochemistry; Leucovorin; Male; Middle Aged; Pilot Projects; Prognosis; Tumor Markers, Biological
ISSN:
1532-1827

Full metadata record

DC FieldValue Language
dc.contributor.authorGormley, J Aen_GB
dc.contributor.authorHegarty, S Men_GB
dc.contributor.authorO'Grady, Aen_GB
dc.contributor.authorStevenson, M Ren_GB
dc.contributor.authorBurden, R Een_GB
dc.contributor.authorBarrett, H Len_GB
dc.contributor.authorScott, C Jen_GB
dc.contributor.authorJohnston, J Aen_GB
dc.contributor.authorWilson, R Hen_GB
dc.contributor.authorKay, E Wen_GB
dc.contributor.authorJohnston, P Gen_GB
dc.contributor.authorOlwill, S Aen_GB
dc.date.accessioned2012-06-29T14:34:29Z-
dc.date.available2012-06-29T14:34:29Z-
dc.date.issued2011-11-08-
dc.identifier.citationThe role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study. 2011, 105 (10):1487-94 Br. J. Canceren_GB
dc.identifier.issn1532-1827-
dc.identifier.pmid21989182-
dc.identifier.doi10.1038/bjc.2011.408-
dc.identifier.urihttp://hdl.handle.net/10147/231540-
dc.description.abstractThe aim of this pilot retrospective study was to investigate the immunohistochemical expression of Cathepsin S (CatS) in three cohorts of colorectal cancer (CRC) patients (n=560).en_GB
dc.language.isoenen
dc.rightsArchived with thanks to British journal of canceren_GB
dc.subject.meshAdult-
dc.subject.meshAged-
dc.subject.meshAged, 80 and over-
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols-
dc.subject.meshCathepsins-
dc.subject.meshChemotherapy, Adjuvant-
dc.subject.meshCohort Studies-
dc.subject.meshColorectal Neoplasms-
dc.subject.meshFemale-
dc.subject.meshFluorouracil-
dc.subject.meshHumans-
dc.subject.meshImmunohistochemistry-
dc.subject.meshLeucovorin-
dc.subject.meshMale-
dc.subject.meshMiddle Aged-
dc.subject.meshPilot Projects-
dc.subject.meshPrognosis-
dc.subject.meshTumor Markers, Biological-
dc.titleThe role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study.en_GB
dc.typeArticleen
dc.contributor.departmentFusion Antibodies Ltd, Springbank Industrial Estate, Pembroke Loop Rd, Belfast BT17 0QL, Northern Ireland. julie.gormley@fusionantibodies.comen_GB
dc.identifier.journalBritish journal of canceren_GB
dc.description.provinceLeinsteren

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.